N-Acetyl-D-Glucosamine

Research use only, not for human use.

N-acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derivative of glucose. It is released by the action of O-GlcNAcase, in mammalian systems from proteins that have been post-translationally modified with O-GlcNAc.

Acetylglucosamine or N-acetylglucosamine is potentially for the treatment of irritable bowel syndrome. N-Acetylglucosamine (GlcNAc) is a monosaccharide that usually polymerizes linearly through (1,4)-β-linkages. GlcNAc is the monomeric unit of the polymer chitin, the second most abundant carbohydrate after cellulose. In addition to serving as a component of this homogeneous polysaccharide, GlcNAc is also a basic component of hyaluronic acid and keratin sulfate on the cell surface. GlcNAc has been reported to be an inhibitor of elastase release from human polymorphonuclear leukocytes (range 8–17% inhibition), however this is much weaker than the inhibition seen with N-acetylgalactosamine (range 92–100%).

——

——

Acetylglucosamine | GlcNAc | Bio-NAG | GreenNAG

Cell Cycle/DNA Damage

Topoisomerase

Human Endogenous Metabolite

——

——

7512-17-6

221.21

C8H15NO6

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (565.07 mM)

OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O

N-Acetyl-beta-D-glucosamine

(-20℃)

With Ice Pack

≥ 2 years